Adherex Technologies (FENC)
(Real Time Quote from BATS)
$5.29 USD
+0.05 (0.95%)
Updated Sep 23, 2024 02:06 PM ET
5-Strong Sell of 5 5
D Value A Growth A Momentum A VGM
Price, Consensus and EPS Surprise
FENC 5.29 +0.05(0.95%)
Will FENC be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for FENC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for FENC
Adherex Technologies Inc. (FENC) Reports Q2 Loss, Lags Revenue Estimates
Fortrea Holdings Inc. (FTRE) Reports Q2 Loss, Lags Revenue Estimates
FENC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Anika Therapeutics (ANIK) Q2 Earnings Lag Estimates
Halozyme Therapeutics (HALO) Q2 Earnings and Revenues Beat Estimates
Implied Volatility Surging for Fennec (FENC) Stock Options
Other News for FENC
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
Fennec price target lowered by $2 at H.C. Wainwright, here's why
Fennec price target lowered by $2 at Craig-Hallum, here's why
Buy Rating for Fennec Pharmaceuticals Bolstered by Pedmark’s Market Expansion and New Leadership
Fennec Pharmaceuticals Inc (FENC) Q2 2024 Earnings Call Transcript Highlights: Strong Revenue ...